OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
December 01, 2023
We kick off our annual recap series with some reflections from our expert advisory board, on topics ranging from AI and cell therapies, to semaglutide and RSV vaccines.
November 28, 2023
The approval is the first for a systemic therapy to treat desmoid tumors, offering patients an alternative to surgery.
November 24, 2023
Safer discusses how symptoms and quality of life often go unaddressed in the few clinician-patient interactions about primary sclerosing cholangitis.
November 23, 2023
Lassailly discusses the role of bariatric surgery versus weight-loss treatments like semaglutide for patients with MASH.